Prognostic value of P-selectin and sST2 in patients with multiple myeloma

Prognostic value of P-selectin and sST2 in patients with multiple myeloma

Cardiac involvement is one of the most important prognostic markers in multiple myeloma. However, prognostic value of novel biomarkers, such as soluble suppression of tumorigenicity 2 (sST2), P-selectin is unknown in multiple myeloma. The aim of the work was to investigate the additive predictive...

Full description

Bibliographic Details
Main Authors: M. O. Panasenko, B. B. Samura, S. Ya. Dotsenko
Format: Article
Language:English
Published: Zaporozhye State Medical University 2022-11-01
Series:Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki
Subjects:
p-selectin
sst2
cardiovascular risk
multiple myeloma
survival
prognosis
Online Access:http://pharmed.zsmu.edu.ua/article/view/266453/264369

Similar Items

Similar Items